AbbVie (ABBV)

This ETF is one of the easiest ways to generate consistent passive income.

Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Between growth and dividends, these companies have plenty to offer.

Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites.

ONEOK’s 6% Dividend Draws Smart Money Despite a Nearly 30% Drop

Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally

AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth

Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock

Blue Owl Capital Stock Trimmed by Investment Manager, According to Recent Filing

Investment Manager Doubles Down on Regional Bank Stock, According to Recent Filing

In our second Quarterly Call, Motley Fool CEO and co-founder Tom Gardner talked about the current market and what to do about it. Tom also shared five investment ideas.

Could AbbVie be the next big opportunity for investors? Tune in as our experts dissect the company's performance and future potential.

San Francisco, CA – October 22, 2025 – Nurix Therapeutics (NASDAQ: NRIX) has captured significant market attention, with its stock experiencing a notable surge following the announcement of the initiation of its pivotal Phase 2 DAYBreak clinical study. This critical advancement focuses on bexobrutideg (NX-5948), an investigational Bruton's tyrosine kinase (BTK) degrader,

Jason Snipe stays long on AbbVie (ABBV). Guggenheim analyst raises price target. QUALCOMM (QCOM) picked by Jim Lebenthal. Stephanie Link picks Aptiv (APTV). Joe Terranova chooses Palo Alto Networks (PANW).

This Florida Fund Is Betting $21 Million on Vertiv as AI Data Center Growth Accelerates

Abacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market

Greg Miley stated that he will join Novo Nordisk next month as the company’s senior vice president of corporate affairs.

Investors should be able to count on these stocks to deliver steady and growing income over the long term.

These dividend growth stocks merit serious consideration.

Analysts discuss stock performance and potential of AbbVie Inc, Amazon, Sixth Street Specialty Lending, and Datadog. Check out premarket coverage.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".